Health Care Cost of Noncommunicable Diseases Related to Smoking in Indonesia, 2015

Kristina, Susi Ari; Endarti, Dwi; Wiedyaningsih, Chairun; Fahamsya, Arifina; Faizah, Nurul

doi:10.1177/1010539517751311

Cited by 19 publications

(22 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pichón-Riviere et al (2014) estimate the annual direct cost of tobacco-related disease in the Chilean health system at approximately 0.6 percent of GDP. In Indonesia, annual direct health care costs attributable to tobacco consumption amounted to 2.5 percent of GDP in 2015 (Kristina et al 2018). The total economic cost of tobacco use in Bangladesh was estimated at 3 percent of GDP in 2004 (WHO 2007).…”

Section: E Costs Of Tobacco: Life Work and Medical Expendituresmentioning

confidence: 99%

Distributional Effects of Tobacco Taxation: A Comparative Analysis

Fuchs¹,

Icaza²,

Paz³

2019

View full text Add to dashboard Cite

Tobacco taxes have positive impacts on health outcomes. However, policy makers often hesitate to use them because of the perception that poorer households are affected disproportionally more than richer households. This study compares the simulated distributional effects of tobacco tax increases in eight low-and middle-income countries. It applies a standardized extended cost-benefit analysis methodology and relies on comparable data sources across countries. The net effect of raising taxes on cigarettes encompasses the direct negative price shock to household budgets and the long-term benefits of improved health outcomes. The distributional incidence is assessed by estimating decile-specific behavioral responses and relative income gains. The comparative results do not support the claim that tobacco taxes are necessarily regressive. Although welfare losses from the first-order price shock disproportionally affect the poor, these negative shocks are attenuated by greater price-responsiveness among lower-income groups and further offset by higher long-term relative gains through reduced medical expenditures and additional years of productive life as taxes dissuade smoking. In several countries, increasing the price of cigarettes is pro-poor and welfare improving for a large share of the population. Along with raising taxes, policy should aim at encouraging responsiveness to price changes and target tobacco-related medical expenses that disproportionally burden the poor.

show abstract

Section: E Costs Of Tobacco: Life Work and Medical Expendituresmentioning

confidence: 99%

Distributional Effects of Tobacco Taxation: A Comparative Analysis

Fuchs¹,

Icaza²,

Paz³

2019

View full text Add to dashboard Cite

show abstract

“…Several studies have quantified the economic costs of smoking, though most have been carried out in highincome countries. Annual direct health care costs attributable to tobacco use amounted to US$2.2 billion in Indonesia in 2015, which is equivalent to 2.5 percent of GDP (Kristina et al 2018). In Bangladesh, the overall economic cost of tobacco use is estimated at Tk 110 billion (US$1.9 billion) or over 3 percent of GDP in 2004(WHO 2007.…”

Section: Literature Reviewmentioning

confidence: 99%

“…Annual direct health care costs attributable to tobacco use amount to US$2.2 billion (equivalent to 2.5 percent of GDP in 2015). The treatment costs of hypertension, chronic obstructive pulmonary diseases, and ischemic heart disease showed the highest cost burden (Kristina et al 2018). Similarly, a 2008 study estimated the economic loss attributable to tobacco use at US$18.5 billion (NIHRD 2009).…”

Section: Tobacco-related Medical Costsmentioning

confidence: 99%

The Distributional Effects of Tobacco Taxation: The Evidence of White and Clove Cigarettes in Indonesia

Tarlovsky¹,

Hasbun²

2018

View full text Add to dashboard Cite

The Policy Research Working Paper Series disseminates the findings of work in progress to encourage the exchange of ideas about development issues. An objective of the series is to get the findings out quickly, even if the presentations are less than fully polished. The papers carry the names of the authors and should be cited accordingly. The findings, interpretations, and conclusions expressed in this paper are entirely those of the authors. They do not necessarily represent the views of the International Bank for Reconstruction and Development/World Bank and its affiliated organizations, or those of the Executive Directors of the World Bank or the governments they represent.

show abstract

“… 5 For instance, a study in 2015 estimated that the morbidity of smoking-related diseases accounted for almost one million cases, about 21.6% of total cases of chronic diseases in Indonesia, with the treatment cost was estimated at least US$2,177 million, approximately 2.5% of the 2015 gross domestic product (GDP). 6 Chronic diseases such as ischemic heart disease, stroke, diabetes, hypertension and cancer remain the top cause of health loss and disabilities among Indonesians. 7 …”

Section: Introductionmentioning

confidence: 99%

Primary health care policy and vision for community pharmacy and pharmacists in Indonesia

Hermansyah¹,

Wulandari²,

Kristina³

et al. 2020

Pharm Pract (Granada)

View full text Add to dashboard Cite

The practice of community pharmacy in low and middle-income countries, including in Indonesia, is often described as in the state of infancy with several intractable barriers that have been substantially and continuously hampering the practice. Such description might be valid in highlighting how pharmacy is practiced and the conditions within and beyond community pharmacy organizations. Therefore, it is not surprising that the concept of integrating community pharmacy into the primary care system may not be considered in the contemporary discourse despite the fact that community pharmacy has been operating within communities for years. However, in the case of Indonesia, we argue that changes in the health care system within the past decade particularly with the introduction of the universal health coverage (UHC) in 2014, may have significantly amplified the role of pharmacists. There is good evidence which highlights the contribution of pharmacist as a substantial health care element in primary care practice. The initiative for employing pharmacist, identified in this article as primary care pharmacist, in the setting of community health center [puskesmas] and the introduction of affiliated or contracted community pharmacy under the UHC have enabled pharmacist to work together with other primary care providers. Moreover, government agenda under the “Smart Use of Medicines” program [Gema Cermat] recognizes pharmacists as the agent of change for improving the rational use of medicines in the community. Community pharmacy is developing, albeit slowly, and is able to grasp a novel position to deliver pharmacy-related primary care services to the general public through new services, for example drug monitoring and home care. Nevertheless, integrating community pharmacy into primary care is relatively a new notion in the Indonesian setting, and is a challenging process given the presence of barriers in the macro, meso- and micro-level of practice.

show abstract

Health Care Cost of Noncommunicable Diseases Related to Smoking in Indonesia, 2015

Cited by 19 publications

References 12 publications

Distributional Effects of Tobacco Taxation: A Comparative Analysis

Distributional Effects of Tobacco Taxation: A Comparative Analysis

The Distributional Effects of Tobacco Taxation: The Evidence of White and Clove Cigarettes in Indonesia

Primary health care policy and vision for community pharmacy and pharmacists in Indonesia

Contact Info

Product

Resources

About